Src family kinases and HER2 interactions in human breast cancer cell growth and survival (Q30307291)

16 June 2017

Src family kinases and HER2 interactions in human breast cancer cell growth and survival (English)

1 reference

16 June 2017

1 reference

1 reference

Belsches-Jablonski AP

1

1 reference

16 June 2017

Biscardi JS

2

1 reference

16 June 2017

Peavy DR

3

1 reference

16 June 2017

Tice DA

4

1 reference

16 June 2017

Romney DA

5

1 reference

16 June 2017

Parsons SJ

6

1 reference

16 June 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

16 June 2017

1 reference

16 June 2017

20

1 reference

16 June 2017

12

1 reference

16 June 2017

1465-1475

1 reference

Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells.

16 June 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

The neu-oncogene protein as a predictive factor for haematogenous metastases in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Direct linkage of EGF to its receptor: characterization and biological relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Involvement of pp60c-src with two major signaling pathways in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Expression of c-erbB-2 in in situ and in adjacent invasive ductal adenocarcinomas of the female breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Site-specific association of c-Src with epidermal growth factor receptor in A431 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Structural basis of interactions between epidermal growth factor receptor and SH2 domain proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Mechanism of biological synergy between cellular Src and epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Bivalence of EGF-like ligands drives the ErbB signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

A simple method for the fluorescence analysis of nucleic acid-dye complexes in cytological preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

pp60c-src tyrosine kinase, myristylation, and modulatory domains are required for enhanced mitogenic responsiveness to epidermal growth factor seen in cells overexpressing c-src

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

Role of c-Src tyrosine kinase in EGF-induced mitogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

c-Src, receptor tyrosine kinases, and human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

Heregulin-stimulated signaling in rat pheochromocytoma cells. Evidence for ErbB3 interactions with Neu/ErbB2 and p85

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

The biology of erbB-2/neu/HER-2 and its role in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

Integrin-mediated signaling in normal and malignant cells: a role of protein tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

Monoclonal antibodies to Rous sarcoma virus pp60src react with enzymatically active cellular pp60src of avian and mammalian origin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma--a detailed morphological analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

Epidermal growth factor receptor expression as a prognostic indicator in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204205

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204205

1 reference

Dimensions Publication ID

16 June 2017

0 references

1 reference